Omeros (OMER) Research & Development (2010 - 2026)
Omeros recorded quarterly Research & Development of $13.4 million in Q1 2026, down 31.31% quarter-over-quarter from $19.4 million in Q4 2025, and down 43.98% year-over-year from $23.8 million in Q1 2025.
Omeros' Research & Development history runs 17 years deep, the most recent figure standing at $13.4 million for Q1 2026.
- In Q1 2026, Research & Development fell 43.98% year-over-year to $13.4 million; the TTM figure through Mar 2026 stood at $70.8 million (down 39.27% YoY), while the FY2025 annual figure was $81.3 million, down 31.98% from the prior year.
- Research & Development came in at $13.4 million for Q1 2026 at Omeros, down from $19.4 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $45.3 million in Q2 2024 to a low of $13.4 million in Q1 2026.
- A 5-year average of $26.0 million and a median of $24.1 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 53.0% in 2024 and sank 51.47% in 2025, its largest moves.
- Omeros' Research & Development stood at $26.5 million in 2022, then gained by 8.82% to $28.9 million in 2023, then fell by 19.28% to $23.3 million in 2024, then fell by 16.61% to $19.4 million in 2025, then plunged by 31.31% to $13.4 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $13.4 million, $19.4 million, and $16.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 13.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.36 Mn |
| Dec 31, 2025 | 19.45 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Jun 30, 2025 | 22.01 Mn |
| Mar 31, 2025 | 23.85 Mn |
| Dec 31, 2024 | 23.32 Mn |
| Sep 30, 2024 | 24.08 Mn |
| Jun 30, 2024 | 45.35 Mn |
| Mar 31, 2024 | 26.77 Mn |
| Dec 31, 2023 | 28.89 Mn |
| Sep 30, 2023 | 31.73 Mn |
| Jun 30, 2023 | 29.64 Mn |
| Mar 31, 2023 | 24.61 Mn |
| Dec 31, 2022 | 26.55 Mn |
| Sep 30, 2022 | 38.57 Mn |
| Jun 30, 2022 | 23.52 Mn |
| Mar 31, 2022 | 24.09 Mn |
| Dec 31, 2021 | 30.33 Mn |
| Sep 30, 2021 | 25.82 Mn |
| Jun 30, 2021 | 30.13 Mn |
| Mar 31, 2021 | 32.50 Mn |
| Dec 31, 2020 | 23.25 Mn |
| Sep 30, 2020 | 31.32 Mn |
| Jun 30, 2020 | 24.13 Mn |
| Mar 31, 2020 | 28.91 Mn |
| Dec 31, 2019 | 37.22 Mn |
| Sep 30, 2019 | 23.75 Mn |
| Jun 30, 2019 | 19.11 Mn |
| Mar 31, 2019 | 26.26 Mn |
| Dec 31, 2018 | 25.45 Mn |
| Sep 30, 2018 | 26.86 Mn |
| Jun 30, 2018 | 19.41 Mn |
| Mar 31, 2018 | 18.14 Mn |
| Dec 31, 2017 | 15.39 Mn |
| Sep 30, 2017 | 14.84 Mn |
| Jun 30, 2017 | 13.14 Mn |
| Mar 31, 2017 | 12.24 Mn |
| Dec 31, 2016 | 12.54 Mn |
| Sep 30, 2016 | 12.49 Mn |
| Jun 30, 2016 | 10.23 Mn |
| Mar 31, 2016 | 15.43 Mn |
| Dec 31, 2015 | 14.90 Mn |
| Sep 30, 2015 | 13.26 Mn |
| Jun 30, 2015 | 10.90 Mn |
| Mar 31, 2015 | 9.32 Mn |
| Dec 31, 2014 | 11.75 Mn |
| Sep 30, 2014 | 11.77 Mn |
| Jun 30, 2014 | 12.41 Mn |
| Mar 31, 2014 | 12.02 Mn |
| Dec 31, 2013 | -26.06 Mn |
| Sep 30, 2013 | 9.42 Mn |
| Jun 30, 2013 | 9.56 Mn |
| Mar 31, 2013 | 7.13 Mn |
| Dec 31, 2012 | 9.35 Mn |
| Sep 30, 2012 | 7.76 Mn |
| Jun 30, 2012 | 7.56 Mn |
| Mar 31, 2012 | 50,000.00 |
| Dec 31, 2011 | 8.90 Mn |
| Sep 30, 2011 | 5.32 Mn |
| Jun 30, 2011 | 4.08 Mn |
| Mar 31, 2011 | 5.43 Mn |
| Dec 31, 2010 | 6.95 Mn |
| Sep 30, 2010 | 5.32 Mn |
| Jun 30, 2010 | 6.12 Mn |